Ebrahim Delpassand is the founder of RadioMedix. He has led RadioMedix since 2005, spearheading radiopharmaceutical innovation for over two decades.
Ebrahim Delpassand is the Founder, Chairman, and CEO of RadioMedix, a clinical-stage biotechnology company based in Houston, Texas, focusing on targeted radiopharmaceuticals for cancer diagnosis and therapy. He has led RadioMedix since 2005, spearheading radiopharmaceutical innovation for over two decades.
Full founder directory · Investor directory · Company funding database · Fundraising library